BOIP Stock Overview
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Boiron SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €50.60 |
| 52 Week High | €50.60 |
| 52 Week Low | €37.35 |
| Beta | 0.47 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 14.74% |
| 3 Year Change | 15.13% |
| 5 Year Change | -11.23% |
| Change since IPO | 20.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| BOIP | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | -0.7% |
| 1Y | 14.7% | -5.0% | -1.8% |
Return vs Industry: BOIP exceeded the UK Pharmaceuticals industry which returned -7.1% over the past year.
Return vs Market: BOIP exceeded the UK Market which returned -2.4% over the past year.
Price Volatility
| BOIP volatility | |
|---|---|
| BOIP Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 8.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: BOIP has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BOIP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1932 | 2,813 | Valérie Lorentz-Poinsot | www.boiron.fr |
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain.
Boiron SA Fundamentals Summary
| BOIP fundamental statistics | |
|---|---|
| Market cap | €937.56m |
| Earnings (TTM) | €47.62m |
| Revenue (TTM) | €517.36m |
19.6x
P/E Ratio1.8x
P/S RatioIs BOIP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BOIP income statement (TTM) | |
|---|---|
| Revenue | €517.36m |
| Cost of Revenue | €135.11m |
| Gross Profit | €382.25m |
| Other Expenses | €334.63m |
| Earnings | €47.62m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Mar 18, 2024
| Earnings per share (EPS) | 2.74 |
| Gross Margin | 73.88% |
| Net Profit Margin | 9.20% |
| Debt/Equity Ratio | 0.5% |
How did BOIP perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield40%
Payout RatioDoes BOIP pay a reliable dividends?
See BOIP dividend history and benchmarks| Boiron dividend dates | |
|---|---|
| Ex Dividend Date | Oct 18 2023 |
| Dividend Pay Date | Oct 20 2023 |
| Days until Ex dividend | 185 days |
| Days until Dividend pay date | 183 days |
Does BOIP pay a reliable dividends?
See BOIP dividend history and benchmarks